Industry Pulse
0102
CPHI Americas and Its Relevance to the Peptide Synthesizer Industry
2025-08-22
Event: CPHI Americas 
Organizer: Informa Markets
Dates: June 2–4, 2026
Location: Pennsylvania Convention Center, Philadelphia, USA
Official Link ：https://www.cphi.com/americas/en/home.html
CPHI Americas unites pharma professionals across the Americas under one roof, spanning the entire supply chain from development to delivery. It integrates in-person and digital engagement, offering year-round connections and industry insight.
Why It Matters to Peptide Synthesizer Vendors
Machinery & Technology: This zone includes pharmaceutical machinery and technology products, making it directly relevant to vendors of peptide synthesizers, especially those oriented toward research, laboratory automation, and scalable peptide production.
BioProduction: Framed as a hub for biopharmaceutical innovation—including biologics, biosimilars, advanced manufacturing, and biomanufacturing trends—this zone gathers top innovators, manufacturers, and solution providers in biopharma.
BioProduction: Framed as a hub for biopharmaceutical innovation—including biologics, biosimilars, advanced manufacturing, and biomanufacturing trends—this zone gathers top innovators, manufacturers, and solution providers in biopharma.
Why Peptide Synthesizer Companies Should Pay Attention：
Industry Reach: Exhibitors include manufacturers and solution providers actively transforming biopharma production workflows—ideal positioning for showcasing peptide synthesizer platforms or related automation solutions.
Comprehensive Supply Chain Access: With CDMOs, CMOs, drug developers, and research labs all under one roof, the event is well-suited for B2B interactions, partnerships, and demonstrating peptide synthesis capabilities in both R&D and production contexts.
Networking and Content Engagement: CPHI Americas combines a conference program with gala events and digital tools to enhance pre-planned meetings and networking—helpful for targeted engagement with potential buyers in the peptide therapeutics field.
Brand Visibility & Business Generation: Exhibitors benefit from exposure to about 3,700 attendees, with 71% of those having purchasing responsibility, and representation from over 108 countries.
Brand Visibility & Business Generation: Exhibitors benefit from exposure to about 3,700 attendees, with 71% of those having purchasing responsibility, and representation from over 108 countries.
Although CPHI Americas is not dedicated solely to peptide synthesizers, the exhibition’s Machinery & Technology and BioProduction zones make it highly relevant for companies in this field. These areas bring together providers of advanced laboratory equipment, biomanufacturing technologies, and contract development services—creating opportunities for peptide synthesizer manufacturers to showcase solid-phase peptide synthesis (SPPS) platforms, automated synthesis solutions, and scale-up capabilities. By connecting with CDMOs, CMOs, and pharmaceutical innovators, peptide synthesizer vendors can position their technologies as essential tools for accelerating peptide drug development, improving process efficiency, and supporting the growing demand for peptide therapeutics.
Our observation perspective:At the upcoming CPHI Shenzhen 2025 expo, the peptide sector will be a major focus. Peptides are increasingly used in biopharmaceuticals and health tech, especially in drug R&D, innovative therapies, and health product development. With global demand for peptide drugs rising, the expo offers a great exchange and collaboration platform for peptide - related companies, researchers, and investors.